Literature DB >> 20044038

Nestin expression in glial and neuronal progenitors of the developing human spinal ganglia.

Katarina Vukojevic1, Danijel Petrovic, Mirna Saraga-Babic.   

Abstract

Expression of the neural crest marker nestin was studied in glial and neuronal progenitors of developing human spinal ganglia using immunohistochemistry in 10 conceptuses, 5-10 weeks old. Quantification was performed by counting the ratio of positive cells in the total cell number, expressed as mean + or - SD and by the Mann-Whitney test. Strong expression of nestin in the 5th-6th developmental week (56%) decreased to 49% in the foetal period. During the same period, number of PGP9.5-positive cells increased from 38% to 42%. At earliest stages, the number of cells expressing GFAP was two folds higher (21%) than S100 (11%). During further development, their number nearly levelled (23% and 28%, respectively), and finally reached level of 25% for GFAP and 40% for S100. While expression of nestin was constantly higher in the dorsal parts of spinal ganglia, number of PGP9.5-, GFAP- and S100-positive cells was higher in their ventral parts, thus indicating ventral to dorsal direction of spinal ganglia differentiation. Co-localization of nestin and GFAP or nestin and S100 was observed during the whole investigate period, while PGP9.5 did not co-localize with nestin. Some ganglion cells simultaneously co-expressing GFAP and S100 might be satellite cells and immature Schwann cells. We suggest that some nestin-positive cells might be capable to differentiate into neurons during the earliest stages of development. Gangliogenesis seems to be important process during the whole ganglion development. Continuous presence of neural crest cells during development might be important in regenerative processes following damage of the spinal ganglia. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20044038     DOI: 10.1016/j.gep.2009.12.001

Source DB:  PubMed          Journal:  Gene Expr Patterns        ISSN: 1567-133X            Impact factor:   1.224


  6 in total

1.  Schwann cells secrete extracellular vesicles to promote and maintain the proliferation and multipotency of hDPCs.

Authors:  Ziyue Li; Yan Liang; Kuangwu Pan; Hui Li; Mei Yu; Weihua Guo; Guoqing Chen; Weidong Tian
Journal:  Cell Prolif       Date:  2017-08       Impact factor: 6.831

2.  Glycogen accumulation in cardiomyocytes and cardiotoxic effects after 3NPA treatment.

Authors:  Aleksandra Milutinović; Ruda Zorc-Pleskovič
Journal:  Bosn J Basic Med Sci       Date:  2012-02       Impact factor: 3.363

3.  The Expression of Connexin 37, 40, 43, 45 and Pannexin 1 in the Early Human Retina and Choroid Development and Tumorigenesis.

Authors:  Matea Žužul; Mirela Lozić; Natalija Filipović; Samir Čanović; Ana Didović Pavičić; Joško Petričević; Nenad Kunac; Violeta Šoljić; Mirna Saraga-Babić; Suzana Konjevoda; Katarina Vukojevic
Journal:  Int J Mol Sci       Date:  2022-05-25       Impact factor: 6.208

4.  Schwann-spheres derived from injured peripheral nerves in adult mice--their in vitro characterization and therapeutic potential.

Authors:  Takehiko Takagi; Ken Ishii; Shinsuke Shibata; Akimasa Yasuda; Momoka Sato; Narihito Nagoshi; Harukazu Saito; Hirotaka J Okano; Yoshiaki Toyama; Hideyuki Okano; Masaya Nakamura
Journal:  PLoS One       Date:  2011-06-24       Impact factor: 3.240

5.  Prenatal ethanol exposure impairs the formation of radial glial fibers and promotes the transformation of GFAPδ‑positive radial glial cells into astrocytes.

Authors:  Yu Li; Li-Na Zhang; Li Chong; Yue Liu; Feng-Yu Xi; Hong Zhang; Xiang-Long Duan
Journal:  Mol Med Rep       Date:  2021-02-12       Impact factor: 2.952

6.  A population of Nestin-expressing progenitors in the cerebellum exhibits increased tumorigenicity.

Authors:  Peng Li; Fang Du; Larra W Yuelling; Tiffany Lin; Renata E Muradimova; Rossella Tricarico; Jun Wang; Grigori Enikolopov; Alfonso Bellacosa; Robert J Wechsler-Reya; Zeng-jie Yang
Journal:  Nat Neurosci       Date:  2013-10-20       Impact factor: 24.884

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.